1. Pink Sheet
  2. >>Geography

European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform

 
• By Francesca Bruce

The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.

Touch the future,Interface technology, the future of user experience.
The European Commission Is Consulting On Ambitious Reform

In another step towards what looks set to be a major revision of the EU’s pharmaceutical legislation, the European Commission has published a consultation touching on a wide range of areas that are potentially ripe for reform. It is seeking opinions on measures to improve the incentives system, such as linking incentives to how well a company reports R&D costs, and to drive access to medicines by obliging companies to launch their products in most EU markets.

The commission says that the consultation is “the latest step towards an ambitious reform” and is part of its wider...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

EU Fines Alchem Over Buscopan API Cartel

 
• By Dave Wallace

After pursuing Alchem International for breaches of EU antitrust rules – relating to a cartel over the SNBB pharmaceutical ingredient used in Buscopan and its generics – the European Commission has now hit the firm with a €489,000 fine.

Bayesian Statistics In EU Clinical Trials: EMA Discusses Balancing Efficiency With Rigor

 
• By Eliza Slawther

Bayesian statistics could help clinical trial sponsors to include external information in their analyses, but concerns around bias and incorrect conclusions remain, the European Medicines Agency said.

Korea Pre-Review Consultations Help Accelerate R&D

 
• By Jung Won Shin

A system of pre-regulatory review consultations for innovative drugs and devices in South Korea has contributed to the accelerated development of such products.